Solventum Corporation (SOLV) Reports Q2 2025 Results; Mizuho and Wells Fargo Reiterate Their Ratings

Solventum Corporation (NYSE:SOLV) is included in our list of the 12 Cheap Value Stocks to Buy Now According to Seth Klarman.

On August 7, 2025, Solventum Corporation (NYSE:SOLV) announced its results for Q2 2025. The quarter marked the fifth consecutive quarter of positive volume growth, with the company recording sales of $2.2 billion, up 3.9% YoY (2.8% organic). This helped Solventum deliver an adjusted EPS of $1.69, beating expectations, along with an operating cash flow of $169 million.

Looking ahead, Solventum Corporation (NYSE:SOLV) raised its 2025 guidance, expecting organic sales growth of 2.0%-3.0% and adjusted EPS of $5.80-$5.95, thanks to strong performance across all segments during the quarter. Following the strong quarterly performance and raised full-year guidance, on August 8, 2025, Piper Sandler raised its price target on the company from $87 to $94, maintaining an ‘Overweight’ rating. The analyst cited Solventum’s consistent execution. Meanwhile, on the same day, Wells Fargo maintained its ‘Hold’ rating with a $79 target.

Ahead of the planned sale of its Purification & Filtration segment and retention of the Drinking Water Filtration segment, Solventum Corporation (NYSE:SOLV) confirmed its free cash flow guidance of $450-$550 million for 2025.

Solventum Corporation is a global leader in innovative medical technology and solutions. It is included in our list of cheap value stocks to buy.

While we acknowledge the potential of SOLV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 13 Best Oil Refinery Stocks to Buy Right Now and 7 Best Potash Stocks to Buy According to Analysts.

Disclosure: None.